Literature DB >> 28747009

Pilot scale repeated fed-batch fermentation processes of the wine yeast Dekkera bruxellensis for mass production of resveratrol from Polygonum cuspidatum.

Hsiao-Ping Kuo1, Reuben Wang2, Yi-Sheng Lin1, Jinn-Tsyy Lai1, Yi-Chen Lo3, Shyue-Tsong Huang4.   

Abstract

Resveratrol has long been used as an ingredient in functional foods. Currently, Polygonum cuspidatum extract is the greatest natural source for resveratrol because of high concentrations of glycosidic-linked resveratrol. Thus, developing a cost-effective procedure to hydrolyze glucoside could substantially enhance resveratrol production from P. cuspidatum. This study selected Dekkera bruxellensis from several microorganisms based on its bioconversion and enzyme-specific activities. We demonstrated that the cells could be reused at least nine times while maintaining an average of 180.67U/L β-glucosidase activity. The average resveratrol bioconversion efficiency within five rounds of repeated usage was 108.77±0.88%. This process worked effectively when the volume was increased to 1200L, a volume at which approximately 35mgL-1h-1 resveratrol per round was produced. This repeated fed-batch bioconversion process for resveratrol production is comparable to enzyme or cell immobilization strategies in terms of reusing cycles, but without incurring additional costs for immobilization.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dekkera bruxellensis; Polygonum cuspidatum; Repeated fed-batch bioconversion; Resveratrol; β-Glucosidase

Mesh:

Substances:

Year:  2017        PMID: 28747009     DOI: 10.1016/j.biortech.2017.07.053

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  4 in total

1.  An innovative biotransformation to produce resveratrol by Bacillus safensis.

Authors:  Xiaoyan Hu; Yexue Liu; Dengke Li; Wei Feng; Hanmeng Ni; Shan Cao; Fuping Lu; Yu Li
Journal:  RSC Adv       Date:  2019-05-17       Impact factor: 4.036

2.  Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study.

Authors:  Saad Abdulrahman Hussain; Bushra Hassan Marouf; Ziyad Serdar Ali; Runj Simko Ahmmad
Journal:  Clin Interv Aging       Date:  2018-09-05       Impact factor: 4.458

Review 3.  Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential.

Authors:  Shivani Khattar; Sauban Ahmed Khan; Syed Amir Azam Zaidi; Mahdi Darvishikolour; Uzma Farooq; Punnoth Poonkuzhi Naseef; Mohamed Saheer Kurunian; Mohammed Zaafar Khan; Athar Shamim; Mohd Masih Uzzaman Khan; Zeenat Iqbal; Mohd Aamir Mirza
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-01

4.  Protective effect of microorganism biotransformation-produced resveratrol on the high fat diet-induced hyperlipidemia, hepatic steatosis and synaptic impairment in hamsters.

Authors:  Chun-Hung Su; Ho-Lin Wang; Min-Ling Tsai; Yi-Chun Lin; Jiuan-Miaw Liao; Cheng-Chieh Yen; Hung-Chih Ting; Ching-Han Yu
Journal:  Int J Med Sci       Date:  2022-09-11       Impact factor: 3.642

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.